Table 8 Disease progress and outcome of treatment data in a probable or confirmed case of COVID-19

Admission to hospital

Hospitalization

Need for hospitalization, first date of admission to hospital, discharge date, discharge status, hospital name, hospital type, hospital ID/code

Care in an intensive care unit

Receive care in an intensive care unit, Length of stay (LOS) in ICU

Receive ventilation and intubation

Receive mechanical ventilation, the number of ventilator days, need to intubation, the number of intubation days

OVID-19 Medications

The main medications prescribed

Date, chloroquine phosphate, hydroxychloroquine, kaletra (lopinavir/ritonavir), ribavirin, remdesivir, avipiravir, oseltamivir (tamiflu), Atazanavir/ritonavir, plasma transfusion, other(s), please specify, additional comment

The auxiliary medications prescribed

Date, naproxen, azithromycin, IVIG, sofosbuvir/daclatasvir (Sovodak), other(s), please specify, additional comment

Disease complications and outcome

Systemic complications

Sepsis/septic shock, multisystem inflammatory syndrome in children (MIS-C), multiorgan failure, cytokine release syndrome, acute kidney injury (AKI), acute liver injury, hepatitis

Respiratory complications

Pneumonia, ‏acute respiratory distress syndrome (ARDS), respiratory failure

Cardiovascular complications

Myocardial infarction, heart failure, arrhythmias, acute coronary syndrome, endothelialitis, vasculitis, viral myocarditis, other cardiovascular complications

Hematologic complications

Disseminated intravascular coagulation (DIC), thrombocytopenia, leukocytosis, leukocytopenia, pulmonary embolism (PE), deep vein thrombosis (DVT)

Neurologic complications

Cerebrovascular accident (CVA), meningitis, encephalopathy, other neurologic complications

Other complications

Date, the name of complications, additional comment

Outcome

Recovered/healthy, death, not recovered, other(s), please specify